<Things you should know> Correct knowledge about "Age-Related Macular Degeneration" Causes, symptoms, and treatment of Age-Related Macular Degeneration
Age-related macular degeneration is a condition in which abnormalities occur in the macula, the central part of the retina of the eye.
You may experience symptoms such as difficulty seeing what you're trying to look at, or seeing things distorted. Age-related macular degeneration is a prime example of a disease caused by aging of the eyes. If left untreated, it can lead to blindness, but in recent years, treatment methods have advanced, and it is now possible to maintain or even restore vision.
If you experience similar symptoms, please read this first.
Under the supervision of an ophthalmologist, we will provide a detailed explanation of age-related macular degeneration.
Finally, we've included a self-check method, so please try it if you're interested.
What is age-related macular degeneration?
Age-related macular degeneration is a disease in which abnormalities occur in the center of the retina, the part of the eye that corresponds to the film in a camera, as a result of aging, leading to a decline in vision.
Age-related macular degeneration (AMD) is the leading cause of blindness in adults in Europe and North America. While it was previously considered relatively uncommon in Japan, its incidence has been increasing in recent years due to an aging population and the Westernization of lifestyles. A survey conducted in Hisayama Town, Kyushu, showed that the prevalence among those aged 50 and over was 0.87% in 1998, but rose to 1.3% nine years later. Currently, it is the fourth leading cause of blindness in Japan, and is approximately three times more common in men than in women.
What is the macula?
The term "macula" in the disease name refers to the central part of the retina, the part of the eye where light gathers. The retina is lined with photoreceptor cells, which are responsible for detecting light and color. The macula, in particular, is a crucial area of the retina where cells that distinguish the color and fine details of objects are concentrated. The macula is several millimeters in diameter and has a small depression in the center called the fovea. Light entering the eye is concentrated in the fovea.
The macula is the center of the retina, and when the macula functions normally, we can see fine details clearly.
Two types of age-related macular degeneration
Age-related macular degeneration has two types: "exudative" and "atrophic."
To understand each of these, let's first take a closer look at the retina. The upper layer of the retina is the "retinal pigment epithelium," and above that is the "choroid," a tissue with many blood vessels. The choroid supplies nutrients to the retina.
-
About age-related macular degeneration
If the function of cells in the macula declines due to prolonged exposure to light or other reasons, fluid may leak from the choroid, causing the retinal pigment epithelium to detach, or the retinal pigment epithelium and choroid to harden and shrink, resulting in decreased vision.
A condition in which vision is impaired due to the shrinkage of the retinal pigment epithelium and other tissues is called "atrophic age-related macular degeneration."
As macular degeneration continues, substances such as vascular endothelial growth factor (VEGF) are said to act to deliver nutrients from the choroid to the photoreceptor cells, leading to the formation of new blood vessels. These new blood vessels are very fragile and can rupture, causing bleeding, leakage of the fluid component of the blood, or growth that invades the retinal pigment epithelium, leading to accumulated damage. As the retina is damaged by various factors, vision deteriorates. This condition, where vision is impaired due to the formation of new blood vessels, is called "exudative age-related macular degeneration." It is a common type among Japanese people.
-
Age-related macular degeneration (exudative age-related macular degeneration)
Main symptoms of age-related macular degeneration
The macula is a crucial part of the retina, acting as the center for "seeing," so any abnormality there can change how we see.
-
It appears distorted
In many cases, a characteristic symptom that occurs in the early stages is distorted vision (metamorphopsia). This distortion is due to the macula, the central part of the retina, being distorted. The center of the field of vision, that is, what you are trying to look at, is distorted, but the peripheral areas appear normal.
Other symptoms include difficulty seeing the center of the field of vision and blurring in the middle of the field of view.
-
The center appears black.
As the symptoms progress, the center of the eye may become black and invisible (central scotoma). In some cases, the ability to distinguish colors may also occur.
-
decreased visual acuity
As the condition progresses, vision deteriorates. If left untreated, vision can drop below 0.1. In some cases, vision can deteriorate suddenly. However, in most cases, there is no pain. Also, even if vision deteriorates in one eye, the other eye may still be able to see, so the symptoms may go unnoticed. The exudative type often progresses more rapidly. If left untreated for a long time, vision loss can occur.
Main causes of age-related macular degeneration
Age-related macular degeneration occurs when cells in the macula are damaged. The main cause of this damage is thought to be aging.
In addition to aging, the following are listed as risk factors:
- smoking
- Westernization of dietary habits
- A lifestyle lacking in green and yellow vegetables
- Obesity, high blood pressure, dyslipidemia
- UV rays
- Genetics
Testing methods for age-related macular degeneration
In ophthalmology, age-related macular degeneration is diagnosed through the following tests.
-
Medical interview
We will ask about when the symptoms started and what they are, as well as your smoking habits and any other illnesses you may have besides eye problems.
-
Vision test
Since vision loss is a symptom of age-related macular degeneration, we will check the degree of your vision.
-
Amsler Test
The patient looks at a grid-like diagram with each eye individually, checking for distortion, blurred vision, or black areas in the center. This is an essential test for diagnosing age-related macular degeneration.
-
Fundus examination
This examination involves dilating the pupil with eye drops to closely examine the condition of the retina. It also checks for macular hemorrhage, neovascularization, and atrophy.
-
Fluorescein angiography
This test involves injecting a fluorescent dye into a vein in the arm to image and examine the neovascularization (new blood vessel formation) in detail. Video recording may also be performed. It allows us to examine the location, shape, and activity of the new blood vessels.
-
Optical coherence tomography (OCT scan)
This is an examination that examines a cross-section of the macula. Newer machines now allow for a three-dimensional view of retinal swelling and choroidal neovascularization. Because it's a short, minimally invasive examination that doesn't require contrast agents, it can be performed frequently. It's used not only for diagnosis but also for monitoring the patient's progress.
Treatment methods for age-related macular degeneration
While there was once no definitive treatment, advances in medicine have led to the development of new therapies that can now maintain or even improve vision.
-
Drug therapy
This is a new treatment that eliminates neovascularization by suppressing the activity of "vascular endothelial growth factor (VEGF)," which promotes the growth of choroidal neovascularization.
Specifically, the procedure involves injecting a "VEGF inhibitor" into the eyeball. Since anesthesia is administered before the injection, there is virtually no pain. The eye and surrounding area are thoroughly disinfected, and the procedure is performed in a clean environment.
Treatment can be done on an outpatient basis, but patients need to use antibiotic eye drops starting three days before the injection. They also need to use eye drops for two to three days after the injection.
Initially, injections are administered 2-3 times every 4-6 weeks. After that, patients are monitored regularly, and if choroidal neovascularization recurs, injections are given again. This treatment may also be combined with photodynamic therapy.
Since the condition may recur if the injections are stopped, it is important to continue patiently as instructed by your ophthalmologist.
-
photodynamic therapy
In many cases, it is used in combination with drug therapy.
First, a drug that accumulates in neovascularization is administered intravenously. Then, a weak laser is applied to the area where the drug has accumulated to eliminate the neovascularization.
The medication administered intravenously is sensitive to light, so exposure to strong light within 48 hours of treatment may cause complications such as photosensitivity; therefore, caution is necessary.
Even after treatment, your condition will be checked every three months, and further treatment will be provided as needed.
-
Laser photocoagulation
This treatment uses a strong laser beam to burn away newly formed blood vessels. It is performed when new blood vessels are forming far from the fovea. This treatment can prevent the abnormality from spreading to the fovea.
Prevention methods for age-related macular degeneration
To detect age-related macular degeneration early, regular eye examinations are essential. Visit an ophthalmologist at least once a year for a checkup that includes a fundus examination.
The following are some ways to improve your daily life:
-
no smoking
Quitting smoking is essential for preventing age-related macular degeneration. It has been clearly shown that smokers have a higher risk of developing age-related macular degeneration than non-smokers.
-
Supplement intake
It has been found that taking supplements containing vitamins such as vitamin C and vitamin E, as well as zinc, which protect retinal cells from the harmful effects of reactive oxygen species, can lower the risk of developing or progressing age-related macular degeneration.
Furthermore, it is said that increasing the pigment in the macula is also important for protecting the macula. Taking supplements containing ingredients such as lutein and zeaxanthin may be beneficial.
-
Eat green and yellow vegetables
Green and yellow vegetables are rich in lutein and zeaxanthin, which are pigments found in the macula of the eye. It is also important to get vitamin C, vitamin E, and zinc from your diet. Vitamins are abundant in spinach, carrots, and pumpkins, while lutein is found in large quantities in spinach and broccoli.
-
Protect from ultraviolet rays
Ultraviolet rays can damage the retina. Wearing sunglasses with UV protection is a good idea. Darker colors make your pupils appear larger, so lighter tints are recommended.
Self-check method for age-related macular degeneration
You can check yourself whether you have age-related macular degeneration. (Please view on a larger screen.)
*If you wear glasses or contact lenses, please have the examination done while wearing them.
- Hold the diagram about 30 cm away from your eyes and stare at the center dot on the chart with one eye.
Cover your other eye with your hand.
- If you concentrate and stare at the black dot in the center, the lines around it will start to blur.
- If the center of your vision is distorted or lines are broken, you may have age-related macular degeneration. You should see an ophthalmologist.
*Even if you don't have any particular problems, you should have your eyes checked at an ophthalmologist once a year.
Age-related macular degeneration
Frequently Asked Questions (Q&A)
-
If age-related macular degeneration is left untreated without being noticed, will it lead to blindness?
It doesn't necessarily lead to blindness. However, as evidenced by the fact that it's the fourth leading cause of blindness in Japan, it certainly can cause a significant decrease in vision.
-
Is age-related macular degeneration a designated intractable disease? Is it curable?
It is not a designated intractable disease. If the disease progresses and the photoreceptor cells are destroyed, recovery becomes difficult, but recovery is possible if treatment is started early.
It is important to seek treatment before your eyesight is severely impaired.
-
Is it possible to treat age-related macular degeneration using iPS cells?
Currently, research is underway to transplant retinal pigment epithelial cells created from iPS cells into the macula.
-
What precautions should I take after photodynamic therapy?
If your eyes or skin are exposed to direct sunlight or bright indoor lights within 48 hours of treatment, it can cause burns. Avoiding light is extremely important. If you absolutely must go outside, it is important to wear dark sunglasses and cover your skin with clothing. Sunscreen is ineffective. Even after 48 hours, try to avoid light as much as possible until the 5th day.
Supervised by: Dr. Masayoshi Kajita, Director of Kajita Eye Clinic
After graduating from Fukushima Medical University in 1983, he worked as a researcher at the University of California, Berkeley, before opening Kajita Ophthalmology Clinic in 2003. From 2018 to 2021, he served as a Clinical Professor at Tokyo Medical and Dental University School of Medicine. In 2022, he was awarded Honorary Membership by the Japan Contact Lens Society, and in 2023, Honorary Membership by the Japanese Society of Ophthalmic Optics. He currently serves as a councilor of the Japan Ophthalmological Society and a member of the drafting committee for the Japanese Medical Optics JIS standards.